Series Archives - Action Santé Mondiale

Cooperation for development EU, Fight against pandemics, Promoting transparent and needs-driven EU R&D policies, Research and Development

The EU’s next FP10: Public money, private priorities?

The European Union is about to make one of the most consequential decisions of the decade: how to spend €175 billion on research and innovation…

actionsantemondiale16 December 2025

Cooperation for development FR, Fight against pandemics

Health Diplomacy in Action: What to Expect from France’s G7 Presidency?

GHA invited three prominent figures committed to greater global health equity to comment on their expectations for France's G7 presidency in 2026, to highlight what…

actionsantemondiale10 December 2025

Cooperation for development EU, Funding and quality of aid

Funding the future: the EU’s next chapter in development cooperation

GHA invited three experts to comment on the recent trends of EU international partnership, to highlight what is at stake and why the EU needs…

actionsantemondiale5 February 2025

Cooperation for development FR, Malnutrition, Women and children's health

Promoting women’s rights to break the malnutrition cycle

Women and girls are among the first victims of malnutrition in the world. Today, more than a billion of them suffer from malnutrition, micronutrient deficiencies…

actionsantemondiale20 September 2024

Funding and quality of aid, Research and Development

Health and Climate: concrete opportunities for more synergetic work?

Environmental breakdown is the single most important political and geostrategic issue of the decade, if not of the century. Changes to natural life support systems…

actionsantemondiale14 November 2023

Research and Development

AI in health: what role and scope for regulation?

The use of artificial intelligence (AI) technologies in the healthcare sector is experiencing unprecedented growth. AI in healthcare is now an integral part of modern…

actionsantemondiale8 November 2023

Promoting transparent and needs-driven EU R&D policies, Research and Development

Financing TB R&D to eradicate the disease by 2030: the next UNHLM, an opportunity we cannot miss

Despite increased international mobilisation in recent years, tuberculosis continues to be one of the deadliest diseases of our time. It is the 13th most common…

actionsantemondiale13 June 2023

Promoting transparent and needs-driven EU R&D policies

More transparency in the pharmaceutical sector: is the EU up for it?

Approved in November 2020, the EU Pharma Strategy aims to build up more access to affordable medicines, boost competitiveness, innovation and sustainability of the pharmaceutical…

actionsantemondiale28 September 2022

Fight against pandemics, HIV/AIDS, TB & Malaria, Whatever It Takes

The voices of the fight against the 3 pandemics

In autumn 2022, the United States will host the 7th replenishment of the Global Fund to fight AIDS, tuberculosis, and malaria. Despite significant progress made…

actionsantemondiale23 March 2022